LABORATORY NEWS
-
Labcorp Plasma Focus™ Liquid Biopsy Test Now Available
Labcorp (NYSE: LH), a leading global life sciences company, has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted therapy selection for patients with advanced or metastatic solid tumors.
- Sera Prognostics Announces Commercial Changes And Actions To Optimize Business For Market Success Toward Accelerating Test Adoption And Revenue
- Invivoscribe Announces Updated Reimbursement For The LeukoStrat CDx FLT3 Mutation Assay To Select Newly Diagnosed FLT3-ITD Positive AML Patients Eligible For VANFLYTA In Japan
- Oneoncology Presents Abstracts At ASCO Highlighting Importance Of Increasing NGS Testing
- IQVIA & (RED) Announce Groundbreaking Partnership To Support Laboratory System Strengthening
ARCHIVED NEWSLETTER
- 05.23.23 -- 5 Characteristics Of The Automated Microbiology Lab Of The Future
- 05.09.23 -- Protecting Cell And Gene Therapy R&D Against Cyber Threats
- 04.25.23 -- Increase In FDA Inspections + Whistleblower Complaints = Heightened Compliance Scrutiny
- 04.11.23 -- ICH Guideline Q9(R1) On QRM, Part 1: Formality & Risk-based Decisions
- 03.28.23 -- Trends In FDA FY2022 Inspection-based Warning Letters
This website uses cookies to ensure you get the best experience on our website. Learn more